Home › Comparisons › MultiversX vs. Novo Nordisk

MultiversX vs. Novo Nordisk: €1,000 since 21/11/2023

MultiversX (EGLD)

€63.34

-93.7 % since start

Novo Nordisk (NVO)

€410.59

-58.9 % since start

Largest drop

-96.8 %

MultiversX · Novo Nordisk: -76.5 %

MultiversXNovo Nordisk
€1,815€60.41
Prices in euros (source: Yahoo Finance, as of 20/11/2026, 01:37). Dividends on stocks are included in adjusted prices.

What this means

Had you invested €1,000 in MultiversX on 21/11/2023, it would have grown to €63.34 by 19/11/2026 (-93.7 %). The same amount in Novo Nordisk would give €410.59 (-58.9 %). Over this period (3.0 years), Novo Nordisk came out ahead. The largest interim drop was -96.8 % for MultiversX and -76.5 % for Novo Nordisk. Annual volatility was 86.5 % and 44.1 % respectively.

Popular comparisons

Not investment advice. Past performance is not a reliable indicator of future results. Past performance says nothing about future results. This is an automatically generated analysis of public price data, not advice to buy or sell.

Join the Coinstox community on

Telegram